G.Barekat Pharm (XTEH:BRKT1) Interest Expense : IRR Mil (TTM As of Mar. 2017)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. G.Barekat Pharm's interest expense for the six months ended in Mar. 2017 was IRR -1,758,622 Mil. G.Barekat Pharm does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Mar. 2017.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. G.Barekat Pharm's Operating Income for the six months ended in Mar. 2017 was IRR 3,266,692 Mil. G.Barekat Pharm's Interest Expense for the six months ended in Mar. 2017 was IRR -1,758,622 Mil. G.Barekat Pharm's Interest Coverage for the quarter that ended in Mar. 2017 was 1.86. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

G.Barekat Pharm Interest Expense Historical Data

The historical data trend for G.Barekat Pharm's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Interest Expense Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Interest Expense

-1,441,176.00

-1,758,622.00

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Interest Expense	-1,441,176.00	-1,758,622.00

G.Barekat Pharm Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

G.Barekat Pharm (XTEH:BRKT1) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

G.Barekat Pharm's Interest Expense for the six months ended in Mar. 2017 was IRR-1,758,622 Mil. Its Operating Income for the six months ended in Mar. 2017 was IRR3,266,692 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Mar. 2017 was IRR255,897 Mil.

G.Barekat Pharm's Interest Coverage for the quarter that ended in Mar. 2017 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2017 )	/	Interest Expense (Q: Mar. 2017 )
	=	-1	*	3266692	/	-1758622
	=	1.86

The higher the ratio, the stronger the company's financial strength is.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines